TrialNature communications2021

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.

S Y Cindy Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.